Elisabet Manasanch

13PUBLICATIONS
72CO-AUTHORS
Medical mycologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 07, 2026
Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma.

|Feb 06, 2025
Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma.

Li Qin, Luz Yurany Moreno Rueda, Upasana Ray

|Nov 11, 2024
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome.

Matteo Giaccherini, Alyssa I Clay-Gilmour, Romano Liotti

|May 22, 2023
Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.

Nianyi Li, Pei Lin, Zhuang Zuo

|Nov 11, 2022
Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms.

Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido

|Oct 25, 2022
The role of soluble B cell maturation antigen as a biomarker in multiple myeloma.

Mohammed Alomari, Chutima Kunacheewa, Elisabet E Manasanch

Pageof 3

Frequent Collaborators

6 joint publications

Hans Lee

3 joint publications

Robert Z Orlowski

3 joint publications

Chutima Kunacheewa

2 joint publications

Behrang Amini